Is pharma still fearful of the Inflation Reduction Act?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good summer morning! Today, we discuss the big Medicare price negotiations (and the not-entirely-meaningful numbers the White House is touting), see a 75% personnel cut at Lykos Therapeutics, and more.
Read Original Article: Is pharma still fearful of the Inflation Reduction Act? »
